Structure Database (LMSD)

Back

LMSD: Lipid classification search results

C15 isoprenoids (sesquiterpenes) [PR0103]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMPR0103110002 (1E,6E)-gamma-humulene (1E,6E)-1,8,8-trimethyl-5-methylidenecycloundeca-1,6-diene (1E,6E)-humula-1(11),4(13),5-triene C15H24 204.187800
LMPR0103110003 (1E,6Z)-gamma-humulene (1E,6Z)-1,8,8-trimethyl-5-methylidenecycloundeca-1,6-diene (1E,6Z)-humula-1(11),4(13),5-triene C15H24 204.187800
LMPR0103110004 (1Z,6E)-gamma-humulene (1Z,6E)-1,8,8-trimethyl-5-methylidenecycloundeca-1,6-diene (1Z,6E)-humula-1(11),4(13),5-triene C15H24 204.187800
LMPR0103110005 (4E,8E)-beta-humulene (1E,5E)-1,4,4-trimethyl-8-methylidenecycloundeca-1,5-diene (4E,8E)-humula-4,8,11-triene C15H24 204.187800
LMPR0103090010 (1E,4Z)-germacrene B (1E,4Z)-germacra-1(10),4,7(11)-triene (1E,5Z)-1,5-dimethyl-8-(propan-2-ylidene)cyclodeca-1,5-diene C15H24 204.187800
LMPR0103090011 (1Z,4Z)-germacrene B (1Z,4Z)-germacra-1(10),4,7(11)-triene (1Z,5Z)-1,5-dimethyl-8-(propan-2-ylidene)cyclodeca-1,5-diene C15H24 204.187800
LMPR0103090012 (1Z,4E)-germacrene B (1Z,4E)-germacra-1(10),4,7(11)-triene (1Z,5E)-1,5-dimethyl-8-(propan-2-ylidene)cyclodeca-1,5-diene C15H24 204.187800
LMPR0103700005 (+)-epi-isozizaene (3S,3aR,6S)-3,7,7,8-tetramethyl-2,3,4,5,6,7-hexahydro-1H-3a,6-methanoazulene C15H24 204.187800
LMPR0103700006 albaflavenone (3S,3aR,6S)-3,7,7,8-tetramethyl-2,3,4,5,6,7-hexahydro-1H-3a,6-methanoazulen-1-one C15H22O 218.167065
LMPR0103700007 albaflavenol (3S,3aR,6S)-3,7,7,8-tetramethyl-2,3,4,5,6,7-hexahydro-1H-3a,6-methanoazulen-1-ol C15H24O 220.182715
LMPR0103700008 (5R)-albaflavenol (1R,3S,3aR,6S)-3,7,7,8-tetramethyl-2,3,4,5,6,7-hexahydro-1H-3a,6-methanoazulen-1-ol C15H24O 220.182715
LMPR0103700009 (5S)-albaflavenol (1S,3S,3aR,6S)-3,7,7,8-tetramethyl-2,3,4,5,6,7-hexahydro-1H-3a,6-methanoazulen-1-ol C15H24O 220.182715
LMPR0103330005 amorpha-4,11-diene (1R,4R,4aS,8aR)-4,7-dimethyl-1-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,8a-octahydronaphthalene C15H24 204.187800
LMPR0103690005 epi-cedrol cedran-8-ol C15H26O 222.198365
LMPR0103050003 Latia luciferin (1E)-2-methyl-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-1-enyl formate C15H24O2 236.177630
LMPR0103010023 farnesyl triphosphate 3,7,11-trimethyldodeca-2,6,10-trien-1-yl tetrahydrogen triphosphate C15H29O10P3 462.097364
LMPR0103010009 2-cis,6-cis-farnesyl diphosphate (2Z,6Z)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl trihydrogen diphosphate C15H28O7P2 382.131031
LMPR0103010010 2-cis,6-trans-farnesyl diphosphate (2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl trihydrogen diphosphate C15H28O7P2 382.131031
LMPR0103010011 2-trans,6-cis-farnesyl diphosphate (2E,6Z)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl trihydrogen diphosphate C15H28O7P2 382.131031
LMPR0103050004 abscisic aldehyde (2Z,4E)-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-methylpenta-2,4-dienal C15H20O3 248.141245
LMPR0103050005 dihydrophaseic acid (2Z,4E)-5-[(1R,3S,5R,8S)-3,8-dihydroxy-1,5-dimethyl-6-oxabicyclo[3.2.1]oct-8-yl]-3-methylpenta-2,4-dienoic acid C15H22O5 282.146725
LMPR0103050006 dihydrophaseic acid 4-O-beta-D-glucoside (2Z,4E)-5-[(1R,3S,5R,8S)-3-(beta-D-glucopyranosyloxy)-8-hydroxy-1,5-dimethyl-6-oxabicyclo[3.2.1]oct-8-yl]-3-methylpenta-2,4-dienoic acid C21H32O10 444.199550
LMPR0103270004 (+)-5-epi-aristolochene (4R,4aR,6R)-4,4a-dimethyl-6-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,7-octahydronaphthalene 4betaH-eremophila-9,11-diene C15H24 204.187800
LMPR0103050007 epi-dihydrophaseic acid (2Z,4E)-5-[(1R,3R,5R,8S)-3,8-dihydroxy-1,5-dimethyl-6-oxabicyclo[3.2.1]oct-8-yl]-3-methylpenta-2,4-dienoic acid C15H22O5 282.146725
LMPR0103250002 capsidiol (1R,3R,4S,4aR,6R)-4,4a-dimethyl-6-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,7-octahydronaphthalene-1,3-diol 1beta,3alpha,4betaH-eremophila-9,11-diene-1,3-diol C15H24O2 236.177630
LMPR0103050008 (-)-abscisic acid (2Z,4E)-5-[(1R)-1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl]-3-methylpenta-2,4-dienoic acid C15H20O4 264.136160
LMPR0103330006 (+)-8-hydroxycalamenene (5R,8S)-3,8-dimethyl-5-(propan-2-yl)-5,6,7,8-tetrahydronaphthalen-1-ol 7betaH-cadina-1,3,5-trien-2-ol C15H22O 218.167065
LMPR0103190013 alantolactone (3aR,5S,8aR,9aR)-5,8a-dimethyl-3-methylidene-3a,5,6,7,8,8a,9,9a-octahydronaphtho[2,3-b]furan-2(3H)-one C15H20O2 232.146330
LMPR0103090013 alatolide (1E,4Z)-14,15-dihydroxy-8alpha-(2-methylpropanoyloxy)germacra-1(10),4,11(13)-trieno-12,6alpha-lactone C19H26O6 350.172940
LMPR0103420002 amaralin (1aR,1bS,2R,3aS,6aR,7aS,8R,8aS)-8-hydroxy-2,7a-dimethyl-6-methylidene-1a,1b,2,3,3a,6a,7,7a,8,8a-decahydrooxireno[1,2]azuleno[6,5-b]furan-5(6H)-one C15H20O4 264.136160
LMPR0103050009 (6S)-dehydrovomifoliol (4S)-4-hydroxy-3,5,5-trimethyl-4-[(1E)-3-oxobut-1-en-1-yl]cyclohex-2-en-1-one C13H18O3 222.125595
LMPR0103410006 guaiazulene 1,4-dimethyl-7-(propan-2-yl)azulene C15H18 198.140850
LMPR0103410007 guaiol guai-1(5)-en-11-ol C15H26O 222.198365
LMPR0103690006 cedr-8-ene cedr-8-ene C15H24 204.187800
LMPR0103690007 cedrol (8R)-cedran-8-ol C15H26O 222.198365
LMPR0103800002 alpha-santalol (2Z)-5-[(2R,3R,4S)-2,3-dimethyltricyclo[2.2.1.0(2,6)]hept-3-yl]-2-methylpent-2-en-1-ol C15H24O 220.182715
LMPR0103800003 beta-santalol (2Z)-2-methyl-5-[(1S,2R,4R)-2-methyl-3-methylidenebicyclo[2.2.1]hept-2-yl]pent-2-en-1-ol C15H24O 220.182715
LMPR0103190014 (+)-beta-selinene (4aR,7R,8aS)-4a-methyl-1-methylidene-7-(prop-1-en-2-yl)decahydronaphthalene eudesma-4(14),11-diene C15H24 204.187800
LMPR0103010012 (2-trans,6-trans)-farnesal (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienal C15H24O 220.182715
LMPR0103010013 (2-cis,6-trans)-farnesol 3,7,11-trimethyldodeca-2Z,6E,10-trien-1-ol C15H26O 222.198365
LMPR0103330007 Cadalene 4-Isopropyl-1,6-dimethylnaphthalene C15H18 198.140850
LMPR0103060015 alpha-curcumene 1-methyl-4-[(2R)-6-methylhept-5-en-2-yl]benzene C15H22 202.172150
LMPR0103450003 Sugeonol 8S-hydroxy-1,4R,9,9-tetramethyl-3,4,5,6,7,8-hexahydro-3a(R),7-methanoazulen-2-one C15H22O2 234.161980
LMPR0103030002 (R)-Sesquilavandulol 5,9-dimethyl-2R-(prop-1-en-2-yl)deca-4E,8-dien-1-ol C15H26O 222.198365
LMPR0103010016 20:1(5Z)(11Me,15Me,19Me) 11,15,19-trimethyl-5Z-eicosenoic acid C23H44O2 352.334130
LMPR0103010017 22:1(5Z)(13Me,17Me,21Me) 13,17,21-trimethyl-5Z-docosenoic acid C25H48O2 380.365430
LMPR0103010020 20:3(5Z,9Z,17Z)(11Me,15Me,19Me) 11,15,19-trimethyl-5Z,9Z,17Z-eicosatrienoic acid C23H40O2 348.302830
LMPR0103010021 22:3(5Z,9Z,19Z)(13Me,17Me,21Me) 13,17,21-trimethyl-5Z,9Z,19Z-docosatrienoic acid C25H44O2 376.334130
LMPR0103010022 24:3(5Z,9Z,17Z)(15Me,19Me,23Me) 15,19,23-trimethyl-5Z,9Z,17Z-tetracosatrienoic acid C27H48O2 404.365430
LMPR0103010018 20:2(5Z,9Z)(11Me,15Me,19Me) 11,15,19-trimethyl-5Z,9Z-eicosadienoic acid C23H42O2 350.318480